Time to plan the Christmas party! Tips from HR
A Christmas party can help prevent morale from flagging at this time of year. Here are a few tips from HR to help ensure your party goes without a hitch.
The longitudinal history of medicines innovation: Part One
This article is originally published in PharmaPhorum.
Celebrating our Centres – London UCLH
This week we spoke to the team in London at BioResource Centre UCLH about what they’ve been working on and their priorities ahead. Learn about PPIE activity, what various members of the team have to say, how volunteer data is being used, and plans to engage underrepresented groups in the future.
Strategies for combination therapy in oncology: Part one – Business as usual
This is the first in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe.
Cambridge-based electronRx to attend CES® 2024 in Las Vegas
Cambridge-based health tech innovator electronRx is attending the Consumer Technology Association event, CES® in Las Vegas in January 2024 The company will showcase its innovative technology that will revolutionise patient long-term and chronic condition management and understandOptibrium introduces cloud-based version of StarDrop drug discovery platform
Cloud-based version of StarDrop retains all the functionality and interactivity of desktop version with improved accessibility and lower total cost of ownership for customers. Optibrium recently received ISO 27001 accreditation for its information security system.
Accelerating patient access to cell and gene therapies
The first human genome was deciphered two decades ago (an astronomical effort that took 13 years and about $3 billion), and at th
Broken String Biosciences’ INDUCE-seq platform demonstrates impact of structural DNA changes on specificity of CRISPR-Cas9 gene editing
Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity Peer-reviewed data demonstrates the sensitivity of INDUCE-seq DNA break mapping platform, in identifying topology-related off-target evSemarion announces Early Adopter Programme for SemaCyte Microcarrier Platform
SemaCyte Microcarrier Platform addresses limitations within adherent cell assays to accelerate the pace of in vitro drug discovery Early access will further validate the technology and provide feedback on applicability across customer workflowsCognidox announces new e-signature integration with DocuSign
Cognidox already has a built in 'best in class' FDA 21 CFR part 11 compliant e signature solution. We have now added DocuSign integration to make contract management and 3rd party signing of documents even easier.
National Lottery funding enables leap forward in strategy for children’s brain tumour charity, Tom’s Trust
The National Lottery Community Fund has granted children’s brain tumour charity Tom’s Trust more than £400,000, enabling a big leap forward in its strategy to support more families.
Neurodiversity, burnout, and poorer dietary choices: a closer look on employee health
Workplaces play an important role in influencing the health of staff. We spend lots of hours at work.
Springboard welcomes Alex Vasiev in his new role
Springboard Pro, a leading engineering consultancy company based in Cambridge, UK, is pleased to announce the addition of Alex Vasiev to the team as a business development manager and engineer.
Outside the box: scale up your ambitions with a Guardtech Cleanrooms modular
The Guardtech Group’s modular champions are offering flexible solutions that grow and adapt alongside their clients’ aspirations.
Celebrating our Centres - Leicester
This week we spoke to the team at the NIHR BioResource Centre Leicester about community engagement events at supermarkets to promote participation in research. In tandem, we also learn about Leicester’s very own NHS Trust Chief Executive, who has made a personal commitment to health research, recently joining the NIHR BioResource.
Antiverse and GlobalBio, Inc. extend collaboration to advance antibody cancer therapeutics
Cardiff, UK and Massachusetts, US - Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, and GlobalBio, Inc. (GlobalBio), an antibody engineering company developing methods to engineer improved and more developable therapeutic antibodies, announces they will be extending their collaboration to advance immune checkpoint inhibitors in…
Cam AI is offering free CBT sessions for 18-24 years olds
Cam AI writes...
Suffering with anxiety and struggling to get support? Cam AI, a mental health startup, is offering volunteers free Cognitive Behavioural Therapy sessions for anxiety with our accredited therapists*.
Get that 'Movie' experience in a meeting
Making the meeting room experience one step better with AI directed cameras to make sure everything is captured in the room, not just the speaker.
Astex CSO David Rees Honoured as a Hero of Chemistry by the American Chemical Society
Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, congratulates its Chief Scientific Officer (CSO), David Rees PhD, FMedSci, FRSC on being honoured by the American Chemical Society (ACS) Heroes of Chemistry
New event launches - Achieving Net Zero: a toolkit for businesses
Join us for an event on November 8 at St John's Innovation Centre that will help your business achieve its Net Zero ambitions.
Major conference wins for Cambridge
Meet Cambridge, the official conference and events bureau for Cambridge and the surrounding area, has announced a series of major conference wins which will bring approximately 2,700 delegates to Cambridge, worth an estimated value of £2.3mn to the local economy.
Closed Loop Medicine appoints Konstantinos Vlassis as Chief Technology Officer
London, UK - Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that enable personalized dose optimization, announces that it has appointed Konstantinos Vlassis as Chief Technology Officer (CTO).
Owlstone Medical recruits first patient in phase 2 clinical trial for the early detection of lung cancer through breath biopsy
Cambridge, UK - Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced recruitment of the first patient into its EVOLUTION Phase 2 clinical trial following successful achievement of key safety and proof of concept milestones in Phase 1.
Undiagnosed breathing conditions could cause winter NHS crisis
electronRx writes...
How to tackle antimicrobial resistance using diagnostics
Growing up as a child, I thought that antibiotics were the magical answer for most medical issues, be that a persistent sore throat or a high fever.